Breast angiosarcoma is a rare type of breast cancer that begins in the cells lining blood vessels — and sometimes lymph vessels — within the breast. Because it grows from vessel tissue rather than from the ducts or lobules where most breast cancers start, it behaves as a sarcoma, a cancer of connective tissue, that happens to be located in the breast. It is uncommon at any age, and what it means for an individual depends on the full picture in their own pathology report and scans.
Key Takeaways
- Angiosarcoma of the breast starts in the lining of blood or lymph vessels in the breast, not in the milk ducts or lobules.
- It is rare; current figures are published by the American Cancer Society (cancer.org) and the National Cancer Institute (cancer.gov).
- It often appears as a lump or as a bruise-like or discoloured area of skin on the breast rather than a classic hard lump.
- Diagnosis is made by biopsy and pathology examination — imaging alone cannot confirm this type.
- A form called secondary angiosarcoma can arise in tissue treated for an earlier breast cancer; primary angiosarcoma arises on its own.
- Treatment is planned by a specialist team, usually with surgery as the foundation, and individual cases differ a great deal.
What Angiosarcoma Means
Most breast cancers are carcinomas: they start in the glandular tissue — the ducts that carry milk and the lobules that produce it. Angiosarcoma belongs to a different family. Sarcomas start in connective tissues such as muscle, fat, and blood vessels, and angiosarcoma specifically starts in the cells that line the inside of blood vessels or lymph vessels. When it arises in the breast, it grows within the breast’s network of tiny vessels, which is why it can look and feel different from a typical breast lump.
The word itself is descriptive: “angio” refers to vessels, and “sarcoma” to the connective-tissue family of cancers. Our pillar guide, Types of Breast Cancer Compared, shows where vessel-based cancers like this one sit alongside the far more common ductal and lobular types, and our explainers on other uncommon types, such as metaplastic breast cancer and secretory breast carcinoma, cover types that are rare in different ways.
Primary and Secondary Angiosarcoma
Doctors describe breast angiosarcoma in two broad forms. Primary angiosarcoma arises on its own in the breast, with no earlier breast condition behind it. It tends to grow within the breast tissue itself. Secondary angiosarcoma develops in an area that was previously treated for another breast cancer — most often in skin that received radiation therapy, sometimes years after that treatment ended. It usually starts in the skin of the treated breast or chest area, which is one reason any new, persistent skin change on a previously treated breast deserves prompt attention.
The distinction matters to your team because it shapes where the cancer is found and how the surrounding tissue has already been treated. It does not change the need for the same careful steps: biopsy, pathology, and staging scans. If your diagnosis is a secondary angiosarcoma, it is understandable to have difficult feelings about treatment you received for an earlier cancer. Raising those feelings with your team is reasonable, and support is available for the emotional side as well as the medical one.
How It May Appear
Angiosarcoma does not always announce itself the way more common breast cancers do. It may appear as a lump, but it can also show up as a bruise-like patch, a blue or purple discolouration of the skin, skin thickening, or an area that looks like a rash or a cluster of small blood vessels near the surface. Some people first notice a rapid change in the size or shape of one breast. Because vessel tumours can bleed into surrounding tissue, a patch may resemble an ordinary bruise that simply does not fade as a bruise should.
None of these signs confirms anything on its own — many breast changes have harmless causes — but a new discolouration, lump, or skin change that persists should be examined by a doctor promptly rather than watched for months. That is true for any breast change, and it is especially worth acting on quickly if the breast was previously treated.
How It Is Diagnosed
As with other breast cancers, the diagnosis rests on tissue. Imaging — mammogram, ultrasound, or MRI — can show an area of concern and guide where to sample, but angiosarcoma can be difficult to characterise on scans alone, because it is made of vessel tissue that blends with the breast’s normal vessels. A biopsy takes a small sample, and a pathologist examines the cells and runs tests to identify the tumour as one arising from vessel lining cells.
Pathologists also grade sarcomas, describing how abnormal the cells look. Because this type is uncommon, your sample may be reviewed by pathologists who specialise in sarcoma, and your case may be discussed by a team with sarcoma experience even if your care happens at a general hospital. Asking whether your team plans to involve a sarcoma service is a sensible question — not because general teams cannot manage it, but because rare tumours are the situation where subspecialist input is most often sought.
How It Compares With Other Types
| Feature | Breast angiosarcoma | Most breast cancers |
|---|---|---|
| Tissue it starts in | The lining of blood or lymph vessels within the breast | The ducts or lobules of the breast |
| Cancer family | Sarcoma (connective tissue) | Carcinoma (glandular tissue) |
| Typical first sign | A lump, or a bruise-like or discoloured skin area | A lump, or a finding on a screening mammogram |
| What drives planning | Size, grade, extent, and whether it is primary or secondary, assessed by a specialist team | Stage, hormone receptor and HER2 results, grade, and overall health |
The table is a general sketch, not a description of your case. One practical difference stands out: because angiosarcoma is not a carcinoma, the hormone receptor and HER2 framework that shapes most breast cancer drug treatment does not apply to it in the same way — another reason planning leans on sarcoma expertise. Our guide to apocrine breast cancer covers a different uncommon type where, by contrast, that receptor framework is central.
How Treatment Is Generally Planned
Treatment for breast angiosarcoma is planned individually by a specialist team. Surgery to remove the tumour with a margin of healthy tissue is usually the foundation of the plan when the cancer is confined to the breast area. Depending on the size and position of the tumour and whether the breast was treated before, the operation may involve the breast tissue, the skin over it, or both. Whether the lymph nodes under the arm are sampled is decided case by case, since this type spreads differently from typical breast cancers.
Radiation therapy and chemotherapy are sometimes part of the plan and sometimes not; the evidence base for a rare cancer like this is thinner than for common breast cancers, so recommendations draw heavily on specialist experience with sarcomas generally. This article cannot say which combination fits any one person. Individual cases differ — in the tumour’s grade, its extent, the person’s health, and what treatment the area has already had — and those details belong in a conversation with your own doctor and care team. General information about sarcomas and breast cancer is published by the National Cancer Institute at cancer.gov and the American Cancer Society at cancer.org.
Questions to Ask Your Doctor
- Is my angiosarcoma primary, or secondary to earlier treatment — and what does that mean for my plan?
- What grade is the tumour, and how far has it spread based on my scans?
- Will a sarcoma specialist or sarcoma centre be involved in planning my treatment?
- What surgery is being recommended, and how much tissue will be removed?
- Are radiation therapy or chemotherapy being considered in my case, and what would each be intended to do?
- What follow-up and monitoring do you recommend afterwards?
Frequently Asked Questions
Is angiosarcoma really a breast cancer if it starts in blood vessels?
It is a cancer located in the breast, and it is diagnosed and treated through breast and sarcoma services. It belongs to the sarcoma family rather than the carcinoma family that most breast cancers come from, which affects how it is classified and planned for.
Can angiosarcoma be caused by earlier radiation treatment?
A secondary form can develop in skin or tissue that was treated with radiation for an earlier breast cancer, sometimes years later. This is a recognised but uncommon late effect. Any new, lasting skin change on a previously treated breast should be checked promptly.
Does a bruise-like patch on the breast always mean something serious?
No. Most breast discolouration has harmless causes, such as an ordinary knock you may not remember. The reason to get checked is persistence: a patch that does not fade like a normal bruise, or that grows or changes, needs a doctor’s examination.
Why might my team refer me to a sarcoma centre?
Because this type is rare, specialist centres see more of it and plan surgery and follow-up around that experience. A referral or a shared-care arrangement is a normal step for uncommon cancers, not a sign that local care has failed.
Where can I find reliable figures about this type?
Because it is uncommon, robust figures are limited and can change as research develops. Current information is published by the American Cancer Society (cancer.org) and the National Cancer Institute (cancer.gov). Your care team can explain what the available evidence means for your situation.
Related Articles
- Types of Breast Cancer Compared: A Complete Guide
- Metaplastic Breast Cancer Explained
- Secretory Breast Carcinoma Explained
- Adenoid Cystic Carcinoma of the Breast Explained
- Apocrine Breast Cancer Explained
This article is for general educational purposes only and is not medical, legal, or financial advice. It does not replace professional care. Talk to your doctor or care team about your own situation. If you think you may have a medical emergency, call 911.